Document Detail


Clinical consequences of the autonomic imbalance in hypertension and congestive heart failure.
MedLine Citation:
PMID:  9540130     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The reduction of coronary mortality is not as large as one would expect from the observed blood pressure lowering in trials of antihypertensive medications. This is not surprising; hypertension is a complex disease where the high blood pressure is only one of numerous coronary risk factors. Sympathetic overactivity in hypertension, independent of the blood pressure, may be conducive to premature atherosclerosis by inducing insulin resistance and dyslipidemia. Through its trophic effect on blood vessels, sympathetic overactivity potentiates vasoconstriction. This, in turn, accelerates hypertension and the metabolic syndrome. The hypertrophy of small coronary arterioles decreases the coronary reserve and enhances coronary spasms. Tachycardia, which is due to increased sympathetic tone and a decreased parasympathetic tone, favors arrhythmias and sudden death in congestive heart failure and hypertension. Increased hematocrit is frequently found in male patients with hypertension, and high hematocrit is a predictor of coronary heart disease/thrombosis. The increase of hematocrit is in part due to an alpha adrenergic postcapillary venoconstriction. Enhanced sympathetic drive, insulin resistance and dyslipidemia have been demonstrated also in congestive heart failure, but the clinical importance of these findings is not fully understood.
Authors:
S Julius; S Nesbitt
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Scandinavian cardiovascular journal. Supplement     Volume:  47     ISSN:  1401-7458     ISO Abbreviation:  Scand Cardiovasc J Suppl     Publication Date:  1998  
Date Detail:
Created Date:  1998-05-21     Completed Date:  1998-05-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9711058     Medline TA:  Scand Cardiovasc J Suppl     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  23-30     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antihypertensive Agents / therapeutic use
Autonomic Nervous System / physiopathology*
Blood Pressure / drug effects
Heart Failure / physiopathology*
Humans
Hypertension / drug therapy,  physiopathology*
Muscle, Smooth, Vascular / innervation,  physiopathology
Vasoconstriction / physiology
Grant Support
ID/Acronym/Agency:
DK 20572/DK/NIDDK NIH HHS; HL 37464/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive t...
Next Document:  Treating hypertension--effect of treatment and cost-effectiveness in respect to later cardiovascular...